In the current study, an ERK inhibitor not only reduced susceptibility to epilepsy but also protected neurons from excitotoxicity by suppressing DAPK1 activity, indicating that DAPK1 may be a downstream effector of ERK in KA-induced epilepsy models. The gene discussed is DAPK1; the disease is epilepsy.